(Q35079375)

6 August 2017

1 reference

title

Rebeccamycin analogues as anti-cancer agents (English)

1 reference

6 August 2017

Michelle Prudhomme

1

1 reference

6 August 2017

1 February 2003

1 reference

European Journal of Medicinal Chemistry

6 August 2017

1 reference

6 August 2017

38

1 reference

6 August 2017

123-140

1 reference

6 August 2017

2

1 reference

Production and biological activity of rebeccamycin, a novel antitumor agent.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Isolation and structure of rebeccamycin - a new antitumor antibiotic from nocardia aerocoligenes

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Synthesis of Rebeccamycin and 11-Dechlororebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Water soluble derivatives of rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Recent developments of rebeccamycin analogues as topoisomerase I inhibitors and antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

A new antitumor substance, BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Synthesis and biological activities of NB-506 analogues modified at the glucose group

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Formaldehyde-induced alkylation of a 2'-aminoglucose rebeccamycin derivative to both A.T and G.C base pairs in DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Sequence-selective intercalation of antitumour bis-naphthalimides into DNA. Evidence for an approach via the major groove.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Dimers from dechlorinated rebeccamycin: synthesis, interaction with DNA, and antiproliferative activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses and antiproliferative activities of new rebeccamycin derivatives with the sugar unit linked to both indole nitrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Rebeccamycin analogues from indolo[2,3-c]carbazole

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses and antiproliferative activities of rebeccamycin analogues bearing two 7-azaindole moieties

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Cellular uptake and interaction with purified membranes of rebeccamycin derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Recognition and cleavage of DNA by rebeccamycin- or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900011-4

7 January 2021

10.1016/S0223-5234(03)00011-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12620658